Identification of natural inhibitors of proteins involved in the pathology of Parkinson's disease

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder caused due to the lack of dopamine in the brain. Different drug therapies are available for PD showing excellent efficiency, but most of them are cost intensive and with side effects. All these issues have brought natural products in attention. The present study was designed to identify the potent anti-Parkinson phytochemicals. Proteins that are involved in Parkinson's disease were targeted. In the present study, methylated flavonoids were selected for studies including molecular docking against protein involved in Parkinson's disease such as Murine Keap 1 (5CGJ), brain permeable Polo-like kinase (4I5P), Methionyl tRNA synthetase(1PFU) and Roco-4- kinase( 4F0F).To predict the drug-likeness property of the phytochemicals, Lipinski's rules of five, Caco-2, CMC-like rule and MDCK value were used. By prediction of ADME, drug-likeness properties and toxicity properties of the phytochemicals it can be stated that most of the phytochemicals have the potential to cross the Blood Brain Barrier and have good ROS quenching potential also.